Evidence map›Paper›PMID 31988136›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Endothelial sphingosine 1-phosphate receptors promote vascular normalization and antitumor therapy.

Andreane Cartier, Tani Leigh, Catherine H Liu, Timothy Hla

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
6.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 108 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. In silico pharmacology · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. S1PR1 suppresses lung adenocarcinoma progression through p-STAT1/miR-30c-5 p/FOXA1 pathway.Journal of experimental & clinical cancer research : CR · 2024
    Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Andreane CartierVascular Biology Program, Boston Children's Hospital, Boston, MA 02115.ORCID 0000-0003-0454-0699
Tani LeighDepartment of Surgery, Harvard Medical School, Boston, MA 02115.
Catherine H LiuDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065.
Timothy HlaVascular Biology Program, Boston Children's Hospital, Boston, MA 02115; timothy.hla@childrens.harvard.edu.ORCID 0000-0001-8355-4065
Boston Children's Hospital · USCornell University · USHarvard University · US

Funding

Mechanisms of sphingolipid signaling in vascular health and diseaseR35HL135821 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI HLA, TIMOTHY TUN · 2017 to 2023
$6.3M
Project-002U54DK110805 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI ORKIN, STUART H, ZON, LEONARD IRA · 2016 to 2020
$5.9M
NHLBI NIH HHS R35 HL135821NIDDK NIH HHS U54 DK110805
6 · The paper itself

Abstract

Sphingosine 1-phosphate receptor-1 (S1PR1) is essential for embryonic vascular development and maturation. In the adult, it is a key regulator of vascular barrier function and inflammatory processes. Its roles in tumor angiogenesis, tumor growth, and metastasis are not well understood. In this paper, we show that S1PR1 is expressed and active in tumor vessels. Murine tumor vessels that lack S1PR1 in the vascular endothelium (

Indexed as

AnimalsAntineoplastic AgentsCapillary PermeabilityCell Line, TumorCell ProliferationEndothelium, VascularMiceMice, KnockoutNeoplasms, ExperimentalNeovascularization, PathologicSphingosine-1-Phosphate ReceptorsAntineoplastic AgentsS1pr1 protein, mouseSphingosine-1-Phosphate ReceptorsangiogenesiscancerG protein-coupled receptorimmunotherapysphingosine 1-phosphate

Identifiers

PMID31988136
PMCPMC7022165
OpenAlexW3004409654

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.